
Fate Therapeutics
Stem cell and developmental biology research company using biological mechanisms to develop stem cell therapeutics.
Market cap
$119m
Enterprise value
($38m)
Share price
$1.12 FATE
Authorizing premium user...
Stem cell and developmental biology research company using biological mechanisms to develop stem cell therapeutics.